CFR Steps Back from India Buy

CFR Steps Back from India Buy

Chile Asia M&A

CFR Pharmaceuticals will withdraw its attempt to acquire 50% of India-based Stellence Pharmscience Private Limited, due to terms of its April 4 contract not being met, it says. It does not specify what the terms were, and the company did not respond

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial